Skip to main content

SUMMIT SECURITIES GROUP LLC

Broker-Dealer

Position in NVS — Novartis AG

CIK 1531593 NEW YORK, NY

Position in NVS

as of Mar 31, 2026 · filed Apr 30, 2026
Position Value
$91,650
-$211,637 QoQ
Shares Held
600
-74.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Dec 31, 2020
CallValue
$0
CallShares
0
PutValue
$4,721
PutShares
50

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

SUMMIT SECURITIES GROUP LLC holds $1,674,088 across 8 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $91,650 600
2025-09-30 $303,287 2,365
2025-06-30 $64,377 532
2025-03-31 $22,296 200
2023-12-31 $5,134,425 50,851
2023-06-30 $456,415 4,523
2023-03-31 $92 1
2022-12-31 $190,239 2,097
2022-03-31 $87 1
2020-12-31 $4,721 50
2020-09-30 $4,869 56
2020-06-30 $3,493 40
2020-06-30 $8,384 96
2020-03-31 $4,122 50